Dimensional Fund Advisors’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
Sell
-107,970
Closed -$18.7M 3411
2015
Q1
$18.7M Sell
107,970
-5,546
-5% -$814K 0.01% 1858
2014
Q4
$13M Sell
113,516
-658
-0.6% -$79.7K 0.01% 2089
2014
Q3
$17.8M Sell
114,174
-439
-0.4% -$63.6K 0.01% 1756
2014
Q2
$14.1M Buy
114,613
+105
+0.1% +$11.6K 0.01% 1959
2014
Q1
$11.9M Sell
114,508
-754
-0.7% -$77.2K 0.01% 2041
2013
Q4
$10.4M Sell
115,262
-1,123
-1% -$89.6K 0.01% 2137
2013
Q3
$7.78M Buy
116,385
+5,302
+5% +$365K 0.01% 2288
2013
Q2
$7.35M Buy
+111,083
New +$6.35M 0.01% 2252

Other funds holding SLXP

Dimensional Fund Advisors's SLXP Position: Q2 2015 in Review

Dimensional Fund Advisors sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 107,970 shares — an estimated $18.7M sold.

Dimensional Fund Advisors first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $18.7M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Dimensional Fund Advisors reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
  • Dimensional Fund Advisors sold 107,970 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $18.7M.
  • Dimensional Fund Advisors first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
  • Dimensional Fund Advisors's SALIX PHARMACEUTICALS LTD DEL position peaked at $18.7M in Q1 2015.
  • 1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Dimensional Fund Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.